MECHANISMS OF AGEING AND DEVELOPMENT is a premier academic journal published by Elsevier Ireland Ltd, specializing in the fields of aging and developmental biology. With an impressive Q1 ranking in both categories as of 2023, this journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of the complex biological processes that underlie aging and development. Since its inception in 1972, the journal has steadily contributed to the accumulation of valuable knowledge, maintaining a history of rigorous peer-reviewed articles that explore genetic, molecular, and cellular mechanisms impacting aging and development. Its high Scopus rankings—notably 5th in Aging and 8th in Developmental Biology—underscore its significance in the scientific community. While the journal follows a traditional publishing route without Open Access options, it remains an indispensable resource for those dedicated to the investigation of life’s aging processes and developmental phenomena. With publication projected through to 2024, the MECHANISMS OF AGEING AND DEVELOPMENT continues to shape the discourse within these critical research domains.

Eneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.

MITOCHONDRION is a distinguished peer-reviewed journal published by Elsevier Science Ltd, focusing on the intricate roles of mitochondria in various biological processes. With an ISSN of 1567-7249 and an E-ISSN of 1872-8278, this journal has carved out a significant niche within the fields of Cell Biology, Molecular Biology, and Molecular Medicine, as evidenced by its Q2 ranking in these categories for 2023. The journal emphasizes the latest research on mitochondrial biogenesis, function, and dynamics, making it a pivotal resource for professionals, researchers, and students engaged in cutting-edge mitochondrial studies. With a robust Scopus ranking, placing it in the top percentiles of its categories, MITOCHONDRION not only advances scientific understanding but also fosters collaboration and innovation within the research community. Though it does not offer Open Access, the journal's comprehensive articles and reviews remain indispensable for those striving to unravel the mysteries of mitochondrial biology. For research spanning from its inception in 2001 through its ongoing commitment to 2024, MITOCHONDRION continues to be a vital platform for disseminating high-quality, impactful research in the realm of mitochondrial science.

BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

Aging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.

Aging and Disease is a leading open-access journal published by the International Society on Aging and Disease, dedicated to advancing the understanding of aging and its associated diseases. Since its inception in 2010, the journal has established itself as a vital resource for researchers and practitioners in the fields of Geriatrics, Neurology, Cell Biology, and Pathology. With an impressive Q1 ranking across multiple categories and a robust position in Scopus rankings, including ranks in the top 3% in Geriatrics and Gerontology, it showcases high-quality research that addresses the complexities of aging processes. Each issue presents original articles, reviews, and insights aimed at improving health outcomes for the aging population. The open-access model ensures that valuable research findings are readily available to a global audience, fostering collaboration and innovation. As a go-to publication for scholars, healthcare professionals, and students, Aging and Disease significantly contributes to the multidisciplinary dialogue surrounding aging and its health implications.

Cell Metabolism is an esteemed journal published by CELL PRESS, dedicated to advancing the understanding of metabolic processes within cell biology, molecular biology, and physiology. With an impactful 2023 ranking placing it at Q1 in multiple categories and earning a distinguished position in the top percentiles of its respective fields, this journal serves as an essential resource for researchers, professionals, and students who are investigating the dynamic roles of metabolism in health and disease. Its rigorous peer-review process ensures high-quality publications that reflect the latest advancements in metabolic research. Since its inception in 2005, Cell Metabolism has become a pivotal platform for disseminating critical findings that not only expand scientific knowledge but also foster innovative approaches to tackle metabolic disorders. By prioritizing accessibility and scholarly excellence without the Open Access model, it remains a premier source for cutting-edge research insights.

Nature Aging, published by SPRINGERNATURE in Germany, stands as a premier journal dedicated to advancing the field of aging research. With high-ranking performance indicators, including a Q1 classification in Aging, Geriatrics and Gerontology, and Neuroscience (miscellaneous), this journal emphasizes the interdisciplinary nature of aging studies. Its Scopus rankings highlight its impact, achieving remarkable positions such as #1 in Neuroscience and #2 in both Geriatrics and Biochemistry for aging-related research. Although currently not open access, Nature Aging provides a wealth of cutting-edge research and critical reviews that aid researchers and practitioners in understanding the complexities of aging mechanisms and their implications. As the field continues to evolve from 2021 through 2024, this journal not only facilitates the dissemination of knowledge but also fosters innovative discussions that propel the science of aging forward. Join the vibrant community of scholars and professionals dedicated to solving the challenges associated with aging by engaging with the content published in Nature Aging.

Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.